These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33767984)

  • 1. Whole-Tumor Histogram and Texture Imaging Features on Magnetic Resonance Imaging Combined With Epstein-Barr Virus Status to Predict Disease Progression in Patients With Nasopharyngeal Carcinoma.
    Li Q; Wang T; Huang Y; Li Q; Liu P; Grimm R; Fu C; Zhang Y; Gu Y
    Front Oncol; 2021; 11():610804. PubMed ID: 33767984
    [No Abstract]   [Full Text] [Related]  

  • 2. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
    Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
    Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma.
    Mao J; Fang J; Duan X; Yang Z; Cao M; Zhang F; Lu L; Zhang X; Wu X; Ding Y; Shen J
    Eur Radiol; 2019 Aug; 29(8):4105-4113. PubMed ID: 30617473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogram analysis of quantitative parameters from synthetic MRI: correlations with prognostic factors in nasopharyngeal carcinoma.
    Yang F; Li X; Li Y; Lei H; Du Q; Yu X; Li L; Zhao Y; Xie L; Lin M
    Eur Radiol; 2023 Aug; 33(8):5344-5354. PubMed ID: 37036478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
    Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC
    Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.
    Sriyook A; Lertbutsayanukul C; Jittapiromsak N
    Clin Imaging; 2021 Apr; 72():1-7. PubMed ID: 33190027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment
    Lin HC; Chan SC; Cheng NM; Liao CT; Hsu CL; Wang HM; Lin CY; Chang JT; Ng SH; Yang LY; Yen TC
    Oral Oncol; 2020 May; 104():104628. PubMed ID: 32163890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
    Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
    Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
    Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between nasopharyngeal carcinoma and lymphoma at the primary site using whole-tumor histogram analysis of apparent diffusion coefficient maps.
    Lian S; Zhang C; Chi J; Huang Y; Shi F; Xie C
    Radiol Med; 2020 Jul; 125(7):647-653. PubMed ID: 32072391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histogram analysis of diffusion kurtosis imaging of nasopharyngeal carcinoma: Correlation between quantitative parameters and clinical stage.
    Xu XQ; Ma G; Wang YJ; Hu H; Su GY; Shi HB; Wu FY
    Oncotarget; 2017 Jul; 8(29):47230-47238. PubMed ID: 28525383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-based radiomics as response predictor to radiochemotherapy for metastatic cervical lymph node in nasopharyngeal carcinoma.
    Xu H; Liu J; Huang Y; Zhou P; Ren J
    Br J Radiol; 2021 Jun; 94(1122):20201212. PubMed ID: 33882240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
    Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
    J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
    Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
    Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
    Wu G; Huang W; Xu J; Li W; Wu Y; Yang Q; Liu K; Zhu M; Balasubramanian PS; Li M
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1771-1780. PubMed ID: 34398299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.
    Chan AT; Lo YM; Zee B; Chan LY; Ma BB; Leung SF; Mo F; Lai M; Ho S; Huang DP; Johnson PJ
    J Natl Cancer Inst; 2002 Nov; 94(21):1614-9. PubMed ID: 12419787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
    Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Texture Analysis Based on Sagittal Fat-Suppression and Oblique Axial T2-Weighted Magnetic Resonance Imaging to Identify Lymph Node Invasion Status of Rectal Cancer.
    Song L; Yin J
    Front Oncol; 2020; 10():1364. PubMed ID: 32850437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.